MedDataX Logo

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT ID: NCT06937229

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE3

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-02

Study Completion Date

2029-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 or CN012-0024.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

NCT07011732

Alzheimer Disease
RECRUITING PHASE3

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)

NCT07011745

Alzheimer Disease
RECRUITING PHASE3

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT and KarXT + KarX-EC in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

NCT05980949

Psychosis Associated With Alzheimer's Disease
RECRUITING PHASE3

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

NCT06585787

Alzheimer Disease
RECRUITING PHASE3

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

NCT06976216

Alzheimer's Disease
RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease Agitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

KarXT+KarX-EC

Group Type EXPERIMENTAL

KarXT

Intervention Type DRUG

Specified dose on specified days

KarX-EC

Intervention Type DRUG

Specified dose on specified days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

KarXT

Specified dose on specified days

Intervention Type DRUG

KarX-EC

Specified dose on specified days

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Xanomeline and Trospium Chloride capsule, BMS-986510 Xanomeline enteric capsules, BMS-986519

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must have completed study CN012-0023 or CN012-0024 per protocol.
* Participants must have one identified caregiver who should have sufficient contact (approximately 10 hours a week or more).

Exclusion Criteria

* Participants must not have clinically significant cardiovascular (eg, untreated or unstable hypertension, clinically significant tachycardia), pulmonary, renal, hematologic, GI, endocrine, immunologic, dermatologic, neurologic, or oncologic disease or any other condition that, in the opinion of the investigator, would jeopardize the safety of the participant or the validity of the study results.
Minimum Eligible Age

55 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bristol-Myers Squibb

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bristol-Myers Squibb

Role: STUDY_DIRECTOR

Bristol-Myers Squibb

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Local Institution - 2609

Chandler, Arizona, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1619

Scottsdale, Arizona, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1657

Anaheim, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2620

Canoga Park, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1637

La Jolla, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2625

Long Beach, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2607

Long Beach, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2642

Long Beach, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2613

Pasadena, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1662

Pomona, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2614

San Diego, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1651

Walnut Creek, California, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2602

Bonita Springs, Florida, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2626

Hialeah, Florida, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1602

Miami, Florida, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1618

Miami, Florida, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1609

Miami, Florida, United States

Site Status NOT_YET_RECRUITING

Nuovida Research Center

Miami, Florida, United States

Site Status RECRUITING

Local Institution - 1635

Orlando, Florida, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1612

Port Orange, Florida, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2621

Tampa, Florida, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1636

Gaithersburg, Maryland, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1638

Newton, Massachusetts, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2615

Worcester, Massachusetts, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2618

Ann Arbor, Michigan, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1620

Troy, Michigan, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2256

Saint Paul, Minnesota, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2629

Hattiesburg, Mississippi, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2628

Las Vegas, Nevada, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1649

Las Vegas, Nevada, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1647

West Long Branch, New Jersey, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1656

New Windsor, New York, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2619

Staten Island, New York, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1658

Woodmere, New York, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1601

Monroe, North Carolina, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2608

Morehead City, North Carolina, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2617

Blue Ash, Ohio, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1640

Tulsa, Oklahoma, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1653

Columbia, South Carolina, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2616

Carrollton, Texas, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2605

Cypress, Texas, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1643

El Paso, Texas, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2622

Mesquite, Texas, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2623

San Antonio, Texas, United States

Site Status NOT_YET_RECRUITING

Pantheon Clinical Research, LLC

Bountiful, Utah, United States

Site Status RECRUITING

Local Institution - 1646

Bennington, Vermont, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1644

Seattle, Washington, United States

Site Status NOT_YET_RECRUITING

Local Institution - 1654

Spokane, Washington, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2610

Milwaukee, Wisconsin, United States

Site Status NOT_YET_RECRUITING

Local Institution - 2005

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1001

La Plata, Buenos Aires, Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1002

Mar del Plata, Buenos Aires, Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 2006

Buenos Aires, Buenos Aires F.D., Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1006

Rosario, Santa Fe Province, Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 2004

Buenos Aires, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1003

Buenos Aires, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1004

Córdoba, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 2000

Córdoba, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 2002

Córdoba, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1005

Córdoba, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1000

Córdoba, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 2003

Córdoba, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 2001

Mendoza, , Argentina

Site Status NOT_YET_RECRUITING

Local Institution - 1051

Brasília, Federal District, Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1053

Curitiba, Paraná, Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1052

Curitiba, Paraná, Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1058

Porto Alegre, Rio Grande do Sul, Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1054

Porto Alegre, Rio Grande do Sul, Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1057

Campinas, São Paulo, Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1056

São Paulo, São Paulo, Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1050

Rio de Janeiro, , Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1055

São Paulo, , Brazil

Site Status NOT_YET_RECRUITING

Local Institution - 1100

Sofia, Sofia-Grad, Bulgaria

Site Status NOT_YET_RECRUITING

Local Institution - 1101

Pleven, , Bulgaria

Site Status NOT_YET_RECRUITING

Local Institution - 1103

Razgrad, , Bulgaria

Site Status NOT_YET_RECRUITING

Local Institution - 1102

Varna, , Bulgaria

Site Status NOT_YET_RECRUITING

Local Institution - 1153

Hamilton, Ontario, Canada

Site Status NOT_YET_RECRUITING

Local Institution - 1155

London, Ontario, Canada

Site Status NOT_YET_RECRUITING

Local Institution - 1151

Toronto, Ontario, Canada

Site Status NOT_YET_RECRUITING

Local Institution - 1154

Toronto, Ontario, Canada

Site Status NOT_YET_RECRUITING

Local Institution - 1152

Whitby, Ontario, Canada

Site Status NOT_YET_RECRUITING

Local Institution - 2055

Viña del Mar, Región de Valparaíso, Chile

Site Status NOT_YET_RECRUITING

Local Institution - 2051

Santiago, Santiago Metropolitan, Chile

Site Status NOT_YET_RECRUITING

Local Institution - 2052

Santiago, Santiago Metropolitan, Chile

Site Status NOT_YET_RECRUITING

Local Institution - 2054

Vitacura, Santiago Metropolitan, Chile

Site Status NOT_YET_RECRUITING

Local Institution - 2053

Antofagasta, , Chile

Site Status NOT_YET_RECRUITING

Local Institution - 1553

Zagreb, City of Zagreb, Croatia

Site Status NOT_YET_RECRUITING

Local Institution - 1554

Rijeka, , Croatia

Site Status NOT_YET_RECRUITING

Local Institution - 1551

Split, , Croatia

Site Status NOT_YET_RECRUITING

Local Institution - 1552

Varaždin, , Croatia

Site Status NOT_YET_RECRUITING

Local Institution - 1550

Zagreb, , Croatia

Site Status NOT_YET_RECRUITING

Local Institution - 2107

Olomouc, Olomoucký kraj, Czechia

Site Status NOT_YET_RECRUITING

Local Institution - 2100

Prague, Praha 6, Czechia

Site Status NOT_YET_RECRUITING

Local Institution - 2106

Prague, Praha 8, Czechia

Site Status NOT_YET_RECRUITING

Local Institution - 2103

Brno, South Moravian, Czechia

Site Status NOT_YET_RECRUITING

Local Institution - 2101

Choceň, , Czechia

Site Status NOT_YET_RECRUITING

Local Institution - 2104

Pilsen, , Czechia

Site Status NOT_YET_RECRUITING

Local Institution - 2102

Prague, , Czechia

Site Status WITHDRAWN

Local Institution - 2105

Prague, , Czechia

Site Status WITHDRAWN

Local Institution - 2108

Rychnov nad Kněžnou, , Czechia

Site Status NOT_YET_RECRUITING

Local Institution - 2150

Toulouse, Haute-Garonne, France

Site Status NOT_YET_RECRUITING

Local Institution - 2151

Villeurbanne, Rhône, France

Site Status NOT_YET_RECRUITING

Local Institution - 2153

Lille, , France

Site Status NOT_YET_RECRUITING

Local Institution - 2156

Limoges, , France

Site Status NOT_YET_RECRUITING

Local Institution - 2157

Montpellier, , France

Site Status NOT_YET_RECRUITING

Local Institution - 2152

Paris, , France

Site Status NOT_YET_RECRUITING

Local Institution - 2155

Strasbourg, , France

Site Status NOT_YET_RECRUITING

Local Institution - 2203

Erbach im Odenwald, Hesse, Germany

Site Status NOT_YET_RECRUITING

Local Institution - 2201

Düsseldorf, , Germany

Site Status NOT_YET_RECRUITING

Local Institution - 2205

Halle, , Germany

Site Status NOT_YET_RECRUITING

Local Institution - 2206

Westerstede, , Germany

Site Status NOT_YET_RECRUITING

Local Institution - 1200

Pátrai, Achaḯa, Greece

Site Status NOT_YET_RECRUITING

Local Institution - 1205

Athens, Attica, Greece

Site Status NOT_YET_RECRUITING

Local Institution - 1202

Athens, Attica, Greece

Site Status NOT_YET_RECRUITING

Local Institution - 1203

Chaïdári, Attikí, Greece

Site Status NOT_YET_RECRUITING

Local Institution - 0027

Athens, , Greece

Site Status WITHDRAWN

Local Institution - 1206

Athens, , Greece

Site Status NOT_YET_RECRUITING

Local Institution - 1207

Athens, , Greece

Site Status NOT_YET_RECRUITING

Local Institution - 1201

Ioannina, , Greece

Site Status NOT_YET_RECRUITING

Local Institution - 1204

Thessaloniki, , Greece

Site Status NOT_YET_RECRUITING

Local Institution - 2257

Kalocsa, Bács-Kiskun county, Hungary

Site Status NOT_YET_RECRUITING

Local Institution - 2250

Győr, Győr-Moson-Sopron, Hungary

Site Status NOT_YET_RECRUITING

Local Institution - 2254

Gyöngyös, Heves County, Hungary

Site Status NOT_YET_RECRUITING

Local Institution - 2255

Budapest, , Hungary

Site Status NOT_YET_RECRUITING

Local Institution - 2251

Budapest, , Hungary

Site Status WITHDRAWN

Local Institution - 2253

Budapest, , Hungary

Site Status NOT_YET_RECRUITING

Local Institution - 2252

Debrecen, , Hungary

Site Status NOT_YET_RECRUITING

Local Institution - 1251

Hyderabad, Andhra Pradesh, India

Site Status NOT_YET_RECRUITING

Local Institution - 1255

Ahmedabad, Gujarat, India

Site Status NOT_YET_RECRUITING

Local Institution - 1252

Hyderabad, Telangana, India

Site Status NOT_YET_RECRUITING

Local Institution - 1254

Varanasi, Uttar Pradesh, India

Site Status NOT_YET_RECRUITING

Local Institution - 1250

Kolkata, West Bengal, India

Site Status NOT_YET_RECRUITING

Local Institution - 1256

Delhi, , India

Site Status NOT_YET_RECRUITING

Local Institution - 1253

New Delhi, , India

Site Status NOT_YET_RECRUITING

Local Institution - 2304

Rishon Le'Tzion, Central District, Israel

Site Status NOT_YET_RECRUITING

Local Institution - 2302

Petch Tikva, IL, Israel

Site Status NOT_YET_RECRUITING

Local Institution - 2301

Jerusalem, , Israel

Site Status NOT_YET_RECRUITING

Local Institution - 2303

Netanya, , Israel

Site Status NOT_YET_RECRUITING

Local Institution - 2305

Ramat Gan, , Israel

Site Status NOT_YET_RECRUITING

Local Institution - 2300

Ramat Gan, , Israel

Site Status NOT_YET_RECRUITING

Local Institution - 2351

Napoli, Campania, Italy

Site Status NOT_YET_RECRUITING

Local Institution - 2354

Rome, Lazio, Italy

Site Status NOT_YET_RECRUITING

Local Institution - 2352

Rome, Lazio, Italy

Site Status NOT_YET_RECRUITING

Local Institution - 2353

Milan, Lombardy, Italy

Site Status NOT_YET_RECRUITING

Local Institution - 2350

Pisa, PI, Italy

Site Status NOT_YET_RECRUITING

Local Institution - 2356

Brescia, , Italy

Site Status NOT_YET_RECRUITING

Local Institution - 2355

Isernia, , Italy

Site Status WITHDRAWN

Local Institution - 2357

Roma, , Italy

Site Status NOT_YET_RECRUITING

Local Institution - 1301

Hadano, Kanagawa, Japan

Site Status NOT_YET_RECRUITING

Local Institution - 1307

Kawasaki, Kanagawa, Japan

Site Status NOT_YET_RECRUITING

Local Institution - 1304

Sakai, Osaka, Japan

Site Status NOT_YET_RECRUITING

National Hospital Organization Hizen Psychiatric Center

Kanzaki-Gun Yoshinogari-Cho, Saga-ken, Japan

Site Status RECRUITING

Local Institution - 1300

Karatsu-shi, Saga-ken, Japan

Site Status NOT_YET_RECRUITING

Local Institution - 1305

Bunkyo-ku, Tokyo, Japan

Site Status NOT_YET_RECRUITING

Local Institution - 1302

Fukuoka, , Japan

Site Status NOT_YET_RECRUITING

Local Institution - 1306

Okayama, , Japan

Site Status NOT_YET_RECRUITING

Local Institution - 1308

Shimotsuke-shi, Tochigi, , Japan

Site Status NOT_YET_RECRUITING

Local Institution - 1355

Saltillo, Coahuila, Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1356

Guadajalara, Jalisco, Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1350

Monterrey, Nuevo León, Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1361

Mexico City, , Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1363

Mexico City, , Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1360

Mexico City, , Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1364

Monterrey, , Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1362

San Luis Potosí City, , Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 1352

Tlalnepantla, , Mexico

Site Status NOT_YET_RECRUITING

Local Institution - 2450

Poznan, Greater Poland Voivodeship, Poland

Site Status NOT_YET_RECRUITING

Local Institution - 2454

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Status NOT_YET_RECRUITING

Local Institution - 2456

Chorzów, , Poland

Site Status NOT_YET_RECRUITING

Local Institution - 2455

Katowice, , Poland

Site Status NOT_YET_RECRUITING

Local Institution - 2451

Lublin, , Poland

Site Status NOT_YET_RECRUITING

Local Institution - 2452

Lublin, , Poland

Site Status WITHDRAWN

Local Institution - 2453

Sochaczew, , Poland

Site Status NOT_YET_RECRUITING

Local Institution - 1401

Coimbra, , Portugal

Site Status NOT_YET_RECRUITING

Local Institution - 1402

Guimarães, , Portugal

Site Status NOT_YET_RECRUITING

Local Institution - 1404

Lisbon, , Portugal

Site Status NOT_YET_RECRUITING

Local Institution - 1403

Senhora da Hora, , Portugal

Site Status NOT_YET_RECRUITING

Local Institution - 1400

Torres Vedras, , Portugal

Site Status NOT_YET_RECRUITING

Local Institution - 1450

Bucharest, București, Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1452

Bucharest, București, Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1453

Bucharest, București, Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1454

Bucharest, București, Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1455

Bucharest, București, Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1456

Bucharest, București, Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1458

Bucharest, București, Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1451

Bucharest, , Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1459

Bucharest, , Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1461

Constanța, , Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1457

Iași, , Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1460

Sanpetru /Brasov, , Romania

Site Status NOT_YET_RECRUITING

Local Institution - 1462

Sibiu, , Romania

Site Status NOT_YET_RECRUITING

Local Institution - 2401

Incheon, Incheon Gwang'yeogsi, South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2407

Seoul, Seoul-teukbyeolsi [Seoul], South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2403

Seoul, Seoul-teukbyeolsi [Seoul], South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2406

Seoul, Seoul-teukbyeolsi [Seoul], South Korea

Site Status WITHDRAWN

Local Institution - 2400

Deagu, Taegu-Kwangyǒkshi, South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2409

Incheon, , South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2402

Seoul, , South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2408

Seoul, , South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2405

Seoul, , South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 2404

Seoul, , South Korea

Site Status NOT_YET_RECRUITING

Local Institution - 1510

Getxo, Bizkaia, Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1509

Elche (alicante), , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1508

Madrid, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1505

Madrid, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 0003

Málaga, , Spain

Site Status WITHDRAWN

Local Institution - 1502

Málaga, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1507

Pamplona, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1500

Salamanca, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1503

Seville, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1504

Terrassa, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1506

Valladolid, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1501

Zaragoza, , Spain

Site Status NOT_YET_RECRUITING

Local Institution - 1753

Kaohsiung Niao Sung Dist, Kaohsiung, Taiwan

Site Status NOT_YET_RECRUITING

Local Institution - 1751

Tainan, Taiana, , Taiwan

Site Status NOT_YET_RECRUITING

Local Institution - 1754

Taipei, , Taiwan

Site Status NOT_YET_RECRUITING

Local Institution - 1750

Taipei, , Taiwan

Site Status NOT_YET_RECRUITING

Local Institution - 1752

Taoyuan District, , Taiwan

Site Status NOT_YET_RECRUITING

Local Institution - 2555

Smila, Cherkasy Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2554

Dnipro, Dnipropetrovsk Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2559

Skarzhyntsi, Khmelnytskyi Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2556

Hlevakha, Kyiv Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2566

Hlevakha, Kyiv Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2553

Kyiv, Kyivska Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2552

Lviv, Lviv Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2558

Lviv, Lviv Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2569

Lviv, Lviv Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2567

Oleksandrivka, Odesa Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2551

Vinnytsia, Vinnytsia Oblast, Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2550

Kropyvnytskyi, , Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2568

Odesa, , Ukraine

Site Status NOT_YET_RECRUITING

Local Institution - 2505

Preston, Lancashire, United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2508

Chertsey, Surrey, United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2502

Cambridge, , United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2501

London, , United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2500

London, , United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2510

Motherwell, , United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2507

Redruth, , United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2504

Sheffield, , United Kingdom

Site Status NOT_YET_RECRUITING

Local Institution - 2509

Stafford, , United Kingdom

Site Status WITHDRAWN

Local Institution - 2503

Wolverhampton, , United Kingdom

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Brazil Bulgaria Canada Chile Croatia Czechia France Germany Greece Hungary India Israel Italy Japan Mexico Poland Portugal Romania South Korea Spain Taiwan Ukraine United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

BMS Study Connect Contact Center, www.BMSStudyConnect.com

Role: CONTACT

[email protected]
855-907-3286

First line of the email MUST contain the NCT# and Site #.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Site 2609

Role: primary

Site 1619

Role: primary

Site 1657

Role: primary

Site 2620

Role: primary

Site 1637

Role: primary

Site 2625

Role: primary

Site 2607

Role: primary

Site 2642

Role: primary

Site 2613

Role: primary

Site 1662

Role: primary

Site 2614

Role: primary

Site 1651

Role: primary

Site 2602

Role: primary

Site 2626

Role: primary

Site 1602

Role: primary

Site 1618

Role: primary

Site 1609

Role: primary

Jorge Betancourt, MD, Site 1604

Role: primary

786-616-9853

Site 1635

Role: primary

Site 1612

Role: primary

Site 2621

Role: primary

Site 1636

Role: primary

Site 1638

Role: primary

Site 2615

Role: primary

Site 2618

Role: primary

Site 1620

Role: primary

Site 2256

Role: primary

Site 2629

Role: primary

Site 2628

Role: primary

Site 1649

Role: primary

Site 1647

Role: primary

Site 1656

Role: primary

Site 2619

Role: primary

Site 1658

Role: primary

Site 1601

Role: primary

Site 2608

Role: primary

Site 2617

Role: primary

Site 1640

Role: primary

Site 1653

Role: primary

Site 2616

Role: primary

Site 2605

Role: primary

Site 1643

Role: primary

Site 2622

Role: primary

Site 2623

Role: primary

Jackson Rhudy, Site 2612

Role: primary

801-200-3950

Site 1646

Role: primary

Site 1644

Role: primary

Site 1654

Role: primary

Site 2610

Role: primary

Site 2005

Role: primary

Site 1001

Role: primary

Site 1002

Role: primary

Site 2006

Role: primary

Site 1006

Role: primary

Site 2004

Role: primary

Site 1003

Role: primary

Site 1004

Role: primary

Site 2000

Role: primary

Site 2002

Role: primary

Site 1005

Role: primary

Site 1000

Role: primary

Site 2003

Role: primary

Site 2001

Role: primary

Site 1051

Role: primary

Site 1053

Role: primary

Site 1052

Role: primary

Site 1058

Role: primary

Site 1054

Role: primary

Site 1057

Role: primary

Site 1056

Role: primary

Site 1050

Role: primary

Site 1055

Role: primary

Site 1100

Role: primary

Site 1101

Role: primary

Site 1103

Role: primary

Site 1102

Role: primary

Site 1153

Role: primary

Site 1155

Role: primary

Site 1151

Role: primary

Site 1154

Role: primary

Site 1152

Role: primary

Site 2055

Role: primary

Site 2051

Role: primary

Site 2052

Role: primary

Site 2054

Role: primary

Site 2053

Role: primary

Site 1553

Role: primary

Site 1554

Role: primary

Site 1551

Role: primary

Site 1552

Role: primary

Site 1550

Role: primary

Site 2107

Role: primary

Site 2100

Role: primary

Site 2106

Role: primary

Site 2103

Role: primary

Site 2101

Role: primary

Site 2104

Role: primary

Site 2108

Role: primary

Site 2150

Role: primary

Site 2151

Role: primary

Site 2153

Role: primary

Site 2156

Role: primary

Site 2157

Role: primary

Site 2152

Role: primary

Site 2155

Role: primary

Site 2203

Role: primary

Site 2201

Role: primary

Site 2205

Role: primary

Site 2206

Role: primary

Site 1200

Role: primary

Site 1205

Role: primary

Site 1202

Role: primary

Site 1203

Role: primary

Site 1206

Role: primary

Site 1207

Role: primary

Site 1201

Role: primary

Site 1204

Role: primary

Site 2257

Role: primary

Site 2250

Role: primary

Site 2254

Role: primary

Site 2255

Role: primary

Site 2253

Role: primary

Site 2252

Role: primary

Site 1251

Role: primary

Site 1255

Role: primary

Site 1252

Role: primary

Site 1254

Role: primary

Site 1250

Role: primary

Site 1256

Role: primary

Site 1253

Role: primary

Site 2304

Role: primary

Site 2302

Role: primary

Site 2301

Role: primary

Site 2303

Role: primary

Site 2305

Role: primary

Site 2300

Role: primary

Site 2351

Role: primary

Site 2354

Role: primary

Site 2352

Role: primary

Site 2353

Role: primary

Site 2350

Role: primary

Site 2356

Role: primary

Site 2357

Role: primary

Site 1301

Role: primary

Site 1307

Role: primary

Site 1304

Role: primary

Manabu Hashimoto, Site 1303

Role: primary

0952523231

Site 1300

Role: primary

Site 1305

Role: primary

Site 1302

Role: primary

Site 1306

Role: primary

Site 1308

Role: primary

Site 1355

Role: primary

Site 1356

Role: primary

Site 1350

Role: primary

Site 1361

Role: primary

Site 1363

Role: primary

Site 1360

Role: primary

Site 1364

Role: primary

Site 1362

Role: primary

Site 1352

Role: primary

Site 2450

Role: primary

Site 2454

Role: primary

Site 2456

Role: primary

Site 2455

Role: primary

Site 2451

Role: primary

Site 2453

Role: primary

Site 1401

Role: primary

Site 1402

Role: primary

Site 1404

Role: primary

Site 1403

Role: primary

Site 1400

Role: primary

Site 1450

Role: primary

Site 1452

Role: primary

Site 1453

Role: primary

Site 1454

Role: primary

Site 1455

Role: primary

Site 1456

Role: primary

Site 1458

Role: primary

Site 1451

Role: primary

Site 1459

Role: primary

Site 1461

Role: primary

Site 1457

Role: primary

Site 1460

Role: primary

Site 1462

Role: primary

Site 2401

Role: primary

Site 2407

Role: primary

Site 2403

Role: primary

Site 2400

Role: primary

Site 2409

Role: primary

Site 2402

Role: primary

Site 2408

Role: primary

Site 2405

Role: primary

Site 2404

Role: primary

Site 1510

Role: primary

Site 1509

Role: primary

Site 1508

Role: primary

Site 1505

Role: primary

Site 1502

Role: primary

Site 1507

Role: primary

Site 1500

Role: primary

Site 1503

Role: primary

Site 1504

Role: primary

Site 1506

Role: primary

Site 1501

Role: primary

Site 1753

Role: primary

Site 1751

Role: primary

Site 1754

Role: primary

Site 1750

Role: primary

Site 1752

Role: primary

Site 2555

Role: primary

Site 2554

Role: primary

Site 2559

Role: primary

Site 2556

Role: primary

Site 2566

Role: primary

Site 2553

Role: primary

Site 2552

Role: primary

Site 2558

Role: primary

Site 2569

Role: primary

Site 2567

Role: primary

Site 2551

Role: primary

Site 2550

Role: primary

Site 2568

Role: primary

Site 2505

Role: primary

Site 2508

Role: primary

Site 2502

Role: primary

Site 2501

Role: primary

Site 2500

Role: primary

Site 2510

Role: primary

Site 2507

Role: primary

Site 2504

Role: primary

Site 2503

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html

BMS Clinical Trial Information

https://www.bmsclinicaltrials.com/us/en/clinical-trials/NCT06937229.html

BMS Clinical Trial Patient Recruiting

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-519994-20

Identifier Type: OTHER

Identifier Source: secondary_id

U1111-1316-3903

Identifier Type: OTHER

Identifier Source: secondary_id

CN012-0025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
NCT05665088 TERMINATED PHASE3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
NCT06976203 RECRUITING PHASE3
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
NCT05271552 COMPLETED PHASE3
WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease
NCT05032482 WITHDRAWN NA
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
NCT03765762 COMPLETED PHASE2
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
NCT06651567 RECRUITING PHASE2
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
NCT04241068 TERMINATED PHASE3
Clinical Trial on Agitation in Alzheimer's Dementia
NCT05543681 RECRUITING PHASE2
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
NCT02579252 COMPLETED PHASE2
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
NCT06304883 ACTIVE_NOT_RECRUITING PHASE3
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
NCT04251910 COMPLETED PHASE1/PHASE2
A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities
NCT03639987 TERMINATED PHASE2
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
NCT07284472 NOT_YET_RECRUITING PHASE2/PHASE3
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
NCT05557409 COMPLETED PHASE3
Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment
NCT03446001 COMPLETED PHASE3
Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
NCT00095719 COMPLETED PHASE3
Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
NCT02423200 COMPLETED PHASE2
A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
NCT01862640 COMPLETED PHASE3
Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
NCT01922258 COMPLETED PHASE3
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01689246 COMPLETED PHASE3
A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
NCT06702124 RECRUITING PHASE3
A Study of Seltorexant in Participants With Probable Alzheimer's Disease
NCT05307692 COMPLETED PHASE2
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
NCT05276830 TERMINATED PHASE2
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
NCT05310071 TERMINATED PHASE3
Addressing Dementia Via Agitation-Centered Evaluation
NCT03226522 COMPLETED PHASE2/PHASE3